Gyan Chandra

Array ( [id] => 5921140 [patent_doc_number] => 20020114808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug' [patent_app_type] => new [patent_app_number] => 10/066782 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7179 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114808.pdf [firstpage_image] =>[orig_patent_app_number] => 10066782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048594 [patent_doc_number] => 20020169110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Diagnosis of metastatic cancer by the mts-1 gene' [patent_app_type] => new [patent_app_number] => 10/067618 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 26823 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169110.pdf [firstpage_image] =>[orig_patent_app_number] => 10067618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7676953 [patent_doc_number] => 20040152873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Novel gene bn01 mapping to chromosone 16q24.3' [patent_app_type] => new [patent_app_number] => 10/470700 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19631 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152873.pdf [firstpage_image] =>[orig_patent_app_number] => 10470700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651023 [patent_doc_number] => 20030105001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Pro-apoptotic proteins and DNA molecules encoding them' [patent_app_type] => new [patent_app_number] => 10/055882 [patent_app_country] => US [patent_app_date] => 2002-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9351 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105001.pdf [firstpage_image] =>[orig_patent_app_number] => 10055882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803311 [patent_doc_number] => 07423015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-09 [patent_title] => 'Antihelminthic drugs as a treatment for hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/043877 [patent_app_country] => US [patent_app_date] => 2002-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 28336 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423015.pdf [firstpage_image] =>[orig_patent_app_number] => 10043877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645688 [patent_doc_number] => 07119185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Hormonally up-regulated, neu-tumor-associated kinase' [patent_app_type] => utility [patent_app_number] => 10/032256 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 60 [patent_no_of_words] => 28812 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119185.pdf [firstpage_image] =>[orig_patent_app_number] => 10032256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 273939 [patent_doc_number] => 07560103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Composition and method of using carcinoma tumor cells' [patent_app_type] => utility [patent_app_number] => 10/025195 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18281 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560103.pdf [firstpage_image] =>[orig_patent_app_number] => 10025195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333270 [patent_doc_number] => 20040131617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'P450rai-2(p450 cytochrome 26b),encoding nucleic acid molecules and methods and uses thereof' [patent_app_type] => new [patent_app_number] => 10/433485 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 40057 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131617.pdf [firstpage_image] =>[orig_patent_app_number] => 10433485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761172 [patent_doc_number] => 20030124533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'HIP1 cancer markers' [patent_app_type] => new [patent_app_number] => 10/007047 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27007 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124533.pdf [firstpage_image] =>[orig_patent_app_number] => 10007047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177757 [patent_doc_number] => 20020156023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Lometrexol combination therapy' [patent_app_type] => new [patent_app_number] => 10/010740 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11237 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156023.pdf [firstpage_image] =>[orig_patent_app_number] => 10010740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869498 [patent_doc_number] => 20030082187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Combined cancer treatment methods using antibodies to aminophospholipids' [patent_app_type] => new [patent_app_number] => 09/998833 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 63052 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082187.pdf [firstpage_image] =>[orig_patent_app_number] => 09998833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304163 [patent_doc_number] => 20040115664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method of testing anticancer agent-sensitivity of tumor cells' [patent_app_type] => new [patent_app_number] => 10/432661 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9681 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115664.pdf [firstpage_image] =>[orig_patent_app_number] => 10432661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968680 [patent_doc_number] => 06939955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Hematopoietic growth factor inducible neurokinin-1 gene' [patent_app_type] => utility [patent_app_number] => 10/039272 [patent_app_country] => US [patent_app_date] => 2001-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25703 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939955.pdf [firstpage_image] =>[orig_patent_app_number] => 10039272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682721 [patent_doc_number] => 20030118585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Use of protein biomolecular targets in the treatment and visualization of brain tumors' [patent_app_type] => new [patent_app_number] => 09/983000 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34840 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118585.pdf [firstpage_image] =>[orig_patent_app_number] => 09983000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813198 [patent_doc_number] => 20030072748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (Kca)' [patent_app_type] => new [patent_app_number] => 09/976961 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8047 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072748.pdf [firstpage_image] =>[orig_patent_app_number] => 09976961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865189 [patent_doc_number] => 20030190715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 09/976782 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80671 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190715.pdf [firstpage_image] =>[orig_patent_app_number] => 09976782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844383 [patent_doc_number] => 20020132328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Genes encoding several poly(ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith' [patent_app_type] => new [patent_app_number] => 09/973451 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24313 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132328.pdf [firstpage_image] =>[orig_patent_app_number] => 09973451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858941 [patent_doc_number] => 20020123056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'SGK2 and its uses' [patent_app_type] => new [patent_app_number] => 09/971118 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16221 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123056.pdf [firstpage_image] =>[orig_patent_app_number] => 09971118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438702 [patent_doc_number] => 20020128192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor' [patent_app_type] => new [patent_app_number] => 09/949972 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27035 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128192.pdf [firstpage_image] =>[orig_patent_app_number] => 09949972 [rel_patent_id] =>[rel_patent_doc_number] =>)